Lubiprostone

Back to search

Molecule Structure

Scientific Name

Lubiprostone

Description of the Drug

Lubiprostone is a prostaglandin derivative used to treat constipation caused by irritable bowel syndrome and opioid-use.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01046

Brand Name(s)

Amitiza

Company Owner(s)

Teva Pharmaceuticals Usa Inc, Sucampo Pharma Americas Llc, Anchen Pharmaceuticals Inc, Dr Reddys Laboratories Ltd, Amneal Pharmaceuticals Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Chloride channel protein 2 SINGLE PROTEIN OPENER CHEMBL1628478

Unichem Links

SureChEMBL SCHEMBL217184
DrugBank DB01046
PubChem: Thomson Pharma 16257021 14780722
PubChem 157920
Nikkaji J2.581.749D
EPA CompTox Dashboard DTXSID5048639
DrugCentral 4123
Brenda 75871
ChemicalBook CB4855611 CB32129504
Guide to Pharmacology 4242
rxnorm LUBIPROSTONE AMITIZA
PubChem: Drugs of the Future 12015646
ZINC ZINC000004217732